Political achievements at EU level
2012, 9 October
Complementary & Alternative Medicine: Innovation and Added Value for European Healthcare - a conference held in Brussels at the European Parliament, funded by the European Commission, the Robert Bosch Foundation and some other sponsors. The conference forcefully concluded that the potential that CAM has to maintain health, prevent ill-health, promote healthier lifestyles and contribute to the sustainability of health systems should not be disregarded by the European Union at a time when health funding is under so much pressure from economic and demographic pressures.
2012, 27 March
A Round Table, a joint initiative of the European Parliament Interest Groups MEPs Against Cancer and MEPs for CAM on Cancer and the contribution of Complementary and Alternative Medicine (CAM) was aimed at presenting and discussing what role CAM can play in the treatment of cancer patients.
2011, 11 October
This CAM Interest Group meeting was dedicated to the need for research into health promotion and CAM.
To date, health research has mostly focused on studying diseases and the effect of various therapeutic interventions upon them. Comparable progress in understanding how a state of health can be maintained and how, via prevention and intervention, better health can be attained, needs to be made urgently.
2011, 12 April
The CAM Interest Group meeting of 12 April 2011 was dedicated to healthy ageing and chronic disease management and the potential contribution of Complementary and Alternative Medicine (CAM) in these areas. Middle-aged and older people are increasingly turning to CAM to help maintain their health and to treat their chronic healthcare problems. CAM improves the quality of their lives through helping prevent or slow the onset of chronic conditions that may eventually lead to disability.
2010, 16 November
The CAM Interest Group meeting of 16 November 2010 was dedicated to discussions on the availability of CAM products. In Europe the availability of CAM products, including homeopathic, anthroposophic and herbal medicinal products, is increasingly being reduced by unnecessarily onerous requirements and restrictions that are leading to prohibitive costs for manufacturers.